Takeda Pharmaceutical Company Ltd. has entered an agreement to acquire Shire plc in a transaction valued at $62 billion. The transaction has been approved by both companies’ boards of directors and is expected to close in 1H19. Upon closing, Takeda shareholders will own approximately 50 percent of the combined group.   The acquisition will provide Takeda with an expanded geographic footprint and greater scale with broader access to U.S. and European markets. The combined firms will become a to...